Hepatitis B and C Diagnostics Market by Expected to Witness Excellent Growth In Coming Years
Hepatitis B diagnostic tests include HBV serologic tests, molecular
deoxyribonucleic acid (DNA) tests, histology tests, and laboratory
tests. HBV serologic tests involve the measurement of antigens and
antibodies. Hepatitis C diagnostic tests include anti-HCV serologic
test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV
molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test
used for screening.
The increasing demand for molecular diagnostic of HBV (hepatitis B virus) and HCV (hepatitis C virus) infections is one of the primary drivers for the growth of this market. Molecular diagnosis simplifies sample preparation for high-volume testing and includes identification and profiling of causative agents of infection and the quantification of pathogens to monitor durability of therapy; thus, resulting in sales of around 60% of the overall molecular diagnosis market. Additionally, new companies are also focusing on the development of new products, which, in turn, is expected to change market dynamics for the diagnosis of HBV and HCV infections. For instance, Cepheid recently announced a quantitative test that offers on-demand molecular testing for confirmation of infection and monitoring of HCV and has obtained CE-IVD (in vitro diagnostics) status under the European Directive on in-vitro diagnostic medical devices, making it one of the leading platforms for molecular diagnosis.
Get PDF Sample Copy of the Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=2039948
Increasing incidence of HBV and HCV infections in the Americas will contribute to the growth of the diagnostic market. The Americas will dominate the market, accounting for half of the total market share by 2023. The recent increase in blood transfusion will result in the adoption of third-generation hepatitis C diagnostic tests like HCV enzyme immunoassay that contribute to the growth of the market in this region. Also, the implementation of biomarker-based POC (point-of-care) tests initiated by the government and non-profit organizations, is also expected to drive the market growth as the products are highly accessible and easy to use.
In 2018, the global Hepatitis B and C Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hepatitis B and C Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hepatitis B and C Diagnostics development in United States, Europe and China.
Read Overview of Report with TOC @ https://www.researchmoz.us/global-hepatitis-b-and-c-diagnostics-market-size-status-and-forecast-2019-2025-report.html
The key players covered in this study
Roche Diagnostics
Abbott
Siemens
Qiagen
Alere
bioMrieux
Cepheid
Chembio Diagnostics
DiaSorin
Enzo Life Sciences
Hologic
MedMira
OraSure Technologies
Quest Diagnostics
Quidel Corp
Randox Laboratories
Make an Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=2039948
The study objectives of this report are:
To analyze global Hepatitis B and C Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Hepatitis B and C Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hepatitis B and C Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Website: https://www.researchmoz.us
Email: sales@researchmoz.us
Blog: https://blogreportstudy.blogspot.com/
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
The increasing demand for molecular diagnostic of HBV (hepatitis B virus) and HCV (hepatitis C virus) infections is one of the primary drivers for the growth of this market. Molecular diagnosis simplifies sample preparation for high-volume testing and includes identification and profiling of causative agents of infection and the quantification of pathogens to monitor durability of therapy; thus, resulting in sales of around 60% of the overall molecular diagnosis market. Additionally, new companies are also focusing on the development of new products, which, in turn, is expected to change market dynamics for the diagnosis of HBV and HCV infections. For instance, Cepheid recently announced a quantitative test that offers on-demand molecular testing for confirmation of infection and monitoring of HCV and has obtained CE-IVD (in vitro diagnostics) status under the European Directive on in-vitro diagnostic medical devices, making it one of the leading platforms for molecular diagnosis.
Get PDF Sample Copy of the Report @ https://www.researchmoz.us/enquiry.php?type=S&repid=2039948
Increasing incidence of HBV and HCV infections in the Americas will contribute to the growth of the diagnostic market. The Americas will dominate the market, accounting for half of the total market share by 2023. The recent increase in blood transfusion will result in the adoption of third-generation hepatitis C diagnostic tests like HCV enzyme immunoassay that contribute to the growth of the market in this region. Also, the implementation of biomarker-based POC (point-of-care) tests initiated by the government and non-profit organizations, is also expected to drive the market growth as the products are highly accessible and easy to use.
In 2018, the global Hepatitis B and C Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Hepatitis B and C Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hepatitis B and C Diagnostics development in United States, Europe and China.
Read Overview of Report with TOC @ https://www.researchmoz.us/global-hepatitis-b-and-c-diagnostics-market-size-status-and-forecast-2019-2025-report.html
The key players covered in this study
Roche Diagnostics
Abbott
Siemens
Qiagen
Alere
bioMrieux
Cepheid
Chembio Diagnostics
DiaSorin
Enzo Life Sciences
Hologic
MedMira
OraSure Technologies
Quest Diagnostics
Quidel Corp
Randox Laboratories
Make an Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=2039948
The study objectives of this report are:
To analyze global Hepatitis B and C Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Hepatitis B and C Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Hepatitis B and C Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Website: https://www.researchmoz.us
Email: sales@researchmoz.us
Blog: https://blogreportstudy.blogspot.com/
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Comments
Post a Comment